Table 3.
Hematological results for the 14-day acute toxicity of BALB/c mice treated with Drs B2.
| Parameter | Control | 5 mg/kg | 10 mg/kg | 15 mg/kg | 20 mg/kg |
|---|---|---|---|---|---|
| RBC (10ˆ12/L) | 7.74 ± 1.34 | 8.30 ± 1.75 | 9.85 ± 0.56 | 9.68 ± 0.48 | 9.628 ± 2.34 |
| Hb (g/dL) | 11.64 ± 1.95 | 12.34 ± 2.87 | 14.98 ± 0.90 | 14.76 ± 0.99 | 14.82 ± 3.45 |
| HCT (%) | 36.54 ± 4.89 | 39.94 ± 8.59 | 46.02 ± 2.87 | 44.28 ± 2.89 | 45.88 ± 9.71 |
| MCV (fl) | 47.54 ± 2.32 | 48.14 ± 1.47 | 46.74 ± 1.71 | 45.72 ± 1.31 | 47.78 ± 2.74 |
| MCH (pg) | 15.06 ± 0.32 | 14.82 ± 0.47 | 15.24 ± 0.39 | 15.22 ± 0.46 | 15.36 ± 0.36 |
| MCHC (g/dL) | 31.74 ± 1.13 | 30.82 ± 0.84 | 32.6 ± 0.44 | 33.26 ± 0.13 | 32.14 ± 1.11 |
| WBC (10ˆ9/L) | 13.48 ± 9.05 | 8.69 ± 1.22 | 8.06 ± 1.68 | 14.71 ± 5.93 | 8.602 ± 3.82 |
| NEU (10ˆ9/L) | 6.82 ± 6.42 | 2.24 ± 0.58 | 1.714 ± 0.69 | 5.08 ± 3.87 | 2.224 ± 1.31 |
| LYM (10ˆ9/L) | 6.62 ± 2.81 | 6.45 ± 1.41 | 6.34 ± 1.70 | 9.62 ± 3.46 | 5.978 ± 2.07 |
| PLT (10ˆ9/L) | 745.6 ± 457.90 | 798 ± 567.10 | 367.2 ± 266.5∗ | 569.40 ± 493.6 | 891.4 ± 457.80 |
∗Significantly different from the control (p < 0.05).